# GlaxoSmithKline Manufacturing S.p.A. – FDA Inspection, May 27, 2015

Source: https://www.keypedia.com/records/fda_inspections/glaxosmithkline-manufacturing-spa/11cd01a9-b7be-4ff7-a6b9-3b7a7148d1b7
Source feed: FDA_Inspections

> FDA inspection 934049 of GlaxoSmithKline Manufacturing S.p.A., May 27, 2015. Classification: Voluntary Action Indicated (VAI). 8 citations under 21 CFR part 211. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 934049
- Company Name: GlaxoSmithKline Manufacturing S.p.A.
- Inspection Date: 2015-05-27
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 8

## Related Documents

- [FDA Inspection 1285374 - 2025-05-15](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-manufacturing-spa/6fee4446-b8f0-4691-a877-618dc26c742b)
- FDA Inspection 1244033 - 2023-10-26
- FDA Inspection 1064045 - 2017-09-29
- FDA Inspection 982333 - 2016-07-22
- FDA Inspection 842545 - 2013-07-10

Company: https://www.keypedia.com/companies/glaxosmithkline-manufacturing-spa/11f7427f-c02e-4b80-91dd-f90cbe9b90a9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
